Page last updated: 2024-08-25

zoledronic acid and Bone Marrow Diseases

zoledronic acid has been researched along with Bone Marrow Diseases in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's4 (44.44)24.3611
2020's4 (44.44)2.80

Authors

AuthorsStudies
Cheng, Y; Ji, Q; Liu, B; Liu, D; Liu, M; Yang, Q; Yang, Z; Zhang, B; Zhou, S1
Aitken, D; Antony, B; Blizzard, L; Cai, G; Cicuttini, F; Hill, C; Jones, G; Laslett, LL; March, L; Martel-Pelletier, J; Pelletier, JP; Wang, Y; Winzenberg, T; Wluka, AE1
Aitken, D; Cai, G; Cicuttini, F; Hill, C; Jones, G; Laslett, LL; March, L; Martel-Pelletier, J; Pelletier, JP; Wluka, AE1
Appelt, KA; Meier, C; Müller, F; Suhm, N1
Li, Y; Liu, F; Liu, M; Mao, Y; Wang, X; Yu, D; Zhao, X; Zhu, Z1
Cullen, N; Ferrero, A; Goldberg, A; Rose, B; Singh, D1
Dalbeth, N; Doyle, A; Exeter, M; Jones, P; Lloyd, R; Lobo, M; McQueen, F; Reid, IR; Robinson, E; Taylor, WJ1
Boon, P; Doré, DA; Jones, G; Laslett, LL; Quinn, SJ; Ryan, E; Winzenberg, TM1
Berger, SA; Bogoch, ER; Fornasier, VL; Lee, TC1

Trials

3 trial(s) available for zoledronic acid and Bone Marrow Diseases

ArticleYear
Effect of Intravenous Zoledronic Acid on Tibiofemoral Cartilage Volume Among Patients With Knee Osteoarthritis With Bone Marrow Lesions: A Randomized Clinical Trial.
    JAMA, 2020, 04-21, Volume: 323, Issue:15

    Topics: Aged; Bone Density Conservation Agents; Bone Marrow; Bone Marrow Diseases; Cartilage, Articular; Double-Blind Method; Female; Humans; Infusions, Intravenous; Knee Joint; Male; Middle Aged; Osteoarthritis, Knee; Treatment Failure; Zoledronic Acid

2020
Zoledronic acid does not reduce MRI erosive progression in PsA but may suppress bone oedema: the Zoledronic Acid in Psoriatic Arthritis (ZAPA) Study.
    Annals of the rheumatic diseases, 2011, Volume: 70, Issue:6

    Topics: Adult; Arthritis, Psoriatic; Bone Density Conservation Agents; Bone Marrow Diseases; Diphosphonates; Disease Progression; Edema; Epidemiologic Methods; Female; Finger Joint; Humans; Imidazoles; Magnetic Resonance Imaging; Male; Middle Aged; Treatment Outcome; Wrist Joint; Zoledronic Acid

2011
Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial.
    Annals of the rheumatic diseases, 2012, Volume: 71, Issue:8

    Topics: Acute-Phase Reaction; Aged; Arthralgia; Bone Density Conservation Agents; Bone Marrow Diseases; Diphosphonates; Double-Blind Method; Female; Humans; Imidazoles; Infusions, Intravenous; Knee Joint; Male; Middle Aged; Osteoarthritis, Knee; Outcome Assessment, Health Care; Pain Measurement; Treatment Outcome; Zoledronic Acid

2012

Other Studies

6 other study(ies) available for zoledronic acid and Bone Marrow Diseases

ArticleYear
Calcium phosphate hybrid micelles inhibit orthotopic bone metastasis from triple negative breast cancer by simultaneously killing cancer cells and reprogramming the microenvironment of bone resorption and immunosuppression.
    Acta biomaterialia, 2023, Volume: 166

    Topics: Bone Marrow Diseases; Bone Neoplasms; Calcium Phosphates; Cell Line, Tumor; Docetaxel; Humans; Immunosuppression Therapy; Micelles; Osteolysis; Triple Negative Breast Neoplasms; Tumor Microenvironment; Zoledronic Acid

2023
The association between change in bone marrow lesion size and change in tibiofemoral cartilage volume and knee symptoms.
    Rheumatology (Oxford, England), 2021, 06-18, Volume: 60, Issue:6

    Topics: Arthralgia; Bone Density Conservation Agents; Bone Marrow; Bone Marrow Diseases; Cartilage, Articular; Double-Blind Method; Female; Femur; Glucocorticoids; Humans; Knee Joint; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multicenter Studies as Topic; Osteoarthritis, Knee; Randomized Controlled Trials as Topic; Tibia; Time Factors; Zoledronic Acid

2021
Zoledronic acid is more efficient than ibandronic acid in the treatment of symptomatic bone marrow lesions of the knee.
    Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2020, Volume: 28, Issue:2

    Topics: Aged; Arthralgia; Biomarkers; Bone Density Conservation Agents; Bone Marrow Diseases; Collagen Type I; Denosumab; Dietary Supplements; Diphosphonates; Female; Humans; Ibandronic Acid; Male; Middle Aged; Peptide Fragments; Peptides; Procollagen; Retrospective Studies; Vitamin D; Zoledronic Acid

2020
The inhibition of subchondral bone lesions significantly reversed the weight-bearing deficit and the overexpression of CGRP in DRG neurons, GFAP and Iba-1 in the spinal dorsal horn in the monosodium iodoacetate induced model of osteoarthritis pain.
    PloS one, 2013, Volume: 8, Issue:10

    Topics: Alkylating Agents; Animals; Arthritis, Experimental; Behavior, Animal; Bone Density Conservation Agents; Bone Marrow Diseases; Calcitonin Gene-Related Peptide; Calcium-Binding Proteins; Chronic Pain; Diphosphonates; DNA-Binding Proteins; Fluorescent Antibody Technique; Ganglia, Spinal; Glial Fibrillary Acidic Protein; Imidazoles; Iodoacetates; Knee Joint; Male; Microfilament Proteins; Neurons; Osteoarthritis; Rats; Rats, Sprague-Dawley; Spinal Cord; Weight-Bearing; X-Ray Microtomography; Zoledronic Acid

2013
Bone Marrow Edema Syndrome of the Foot and Ankle: Mid- to Long-Term Follow-up in 18 Patients.
    Foot & ankle specialist, 2016, Volume: 9, Issue:3

    Topics: Adult; Alendronate; Bone Density Conservation Agents; Bone Marrow Diseases; Diphosphonates; Edema; Female; Follow-Up Studies; Foot Diseases; Foot Orthoses; Humans; Imidazoles; Immobilization; Male; Middle Aged; Pain Management; Retrospective Studies; Zoledronic Acid

2016
Articular damage is associated with intraosseous inflammation in the subchondral bone marrow of joints affected by experimental inflammatory arthritis and is modified by zoledronate treatment.
    The Journal of rheumatology, 2007, Volume: 34, Issue:6

    Topics: Animals; Arthritis, Experimental; Bone Density Conservation Agents; Bone Marrow; Bone Marrow Diseases; Carrageenan; CD11b Antigen; CD3 Complex; CD4 Antigens; Diphosphonates; Disease Models, Animal; Female; Imidazoles; Inflammation; Joints; Rabbits; Rats; Rats, Sprague-Dawley; Spleen; Zoledronic Acid

2007